Ginger Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth -9.68%
(FY 2022)
- Total Assets 0.01%
(FY 2022)
About Ginger Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chandra Agrawal, Amitabh Agarwal, and Rajender Chandak serve as directors at the Company.
- CIN/LLPIN
U24232TG2015PTC097855
- Company No.
097855
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ginger Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Agrawal  | Director | 03-Mar-2015 | Current |
| Amitabh Agarwal | Director | 03-Mar-2015 | Current |
| Rajender Chandak | Director | 03-Mar-2015 | Current |
Financial Performance of Ginger Pharma.
Ginger Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 9.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ginger Pharma?
In 2019, Ginger Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bhagyanagar Polymers Pvt LtdActive 34 years 10 monthsChandra Agrawal and Amitabh Agarwal are mutual person
- Bhagyanagar Rubber Products Private LimitedActive 33 years 8 months
Chandra Agrawal and Amitabh Agarwal are mutual person
- Hind Overseas Private LimitedActive 30 years 6 months
Chandra Agrawal and Amitabh Agarwal are mutual person
- Enco Speciality Chemicals Private LimitedActive 2 years 11 months
Rajender Chandak is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ginger Pharma?
Unlock and access historical data on people associated with Ginger Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ginger Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ginger Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
